Seres Therapeutics Inc.

NASDAQ: MCRB · Real-Time Price · USD
16.70
-0.16 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
16.08
-3.74%
After-hours: Aug 15, 2025, 07:58 PM EDT

Seres Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
18.99K -31.52 -47.69 -12.42
PEG Ratio
-189.72 0.51 -0.19 0.33
PS Ratio
n/a 28.37 1.7K 5.27
PB Ratio
187.37 -79.9 1.12K 5.81
P/FCF Ratio
-17.34 -28.6 -50.72 -265.42
P/OCF Ratio
-17.38 -30.54 -52.9 114.22
OCF/S Ratio
n/a -0.93 -32.1 0.05
Debt / Equity Ratio
6.65 -4.77 15.08 0.37
Quick Ratio
0.94 1.48 2.28 3.69
Current Ratio
0.94 1.78 2.28 3.69
Asset Turnover
n/a 0.35 0.02 0.41
Interest Coverage
n/a -8.2 -40.95 -22.16
Return on Equity
0.01 2.54 -23.54 -0.47
Return on Assets
n/a -0.32 -0.73 -0.17
Return on Invested Capital
-1.13 -0.41 -0.94 -0.21
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a 0.99 0.86 0.99
Net Profit Margin
n/a -0.9 -35.61 -0.42
Pretax Profit Margin
n/a -0.9 -35.09 -0.45
Operating Profit Margin
n/a -0.85 -34.58 -0.45
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a -0.75 -33.32 -0.39